Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT00278408
Group ID:
EG004
Title:
Interventional: 6 R-CHOP-21 for Patients Without Radiotherapy Indication
Description:
Arm V (R-CHOP-21): Patients receive R-CHOP immunochemotherapy comprising rituximab IV, cyclophosphamide IV over 15 minutes, doxorubicin IV, and vincristine IV on day 1 and oral prednisone once daily on days 1-5. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity.
rituximab
cyclophosphamide
doxorubicin hydrochloride
prednisone
vincristine sulfate
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
30
Serious Number At Risk:
114
Other Number Affected:
41
Other Number At Risk:
114
Study:
NCT00278408
Results Section:
NCT00278408
Adverse Events Module:
NCT00278408